#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2388854	A	Cmax in Sprague-Dawley rat portal vein blood at 10 mg/kg, po	Rattus norvegicus	49		organism-based format	Scientific Literature
2.	ALA2388855	A	Cmax in Sprague-Dawley rat systemic blood at 10 mg/kg, po	Rattus norvegicus	49		organism-based format	Scientific Literature
3.	ALA2388856	A	Apparent permeability in MDCK cells expressing MDR1 at 3 uM after 60 mins by LC-MS/MS analysis	Canis lupus familiaris	49		cell-based format	Scientific Literature
4.	ALA2388857	B	Inhibition of human ASBT expressed in HEK293 cells assessed as inhibition of [3H]-taurocholate uptake after 90 mins by scintillation counting analysis	Homo sapiens	49		cell-based format	Scientific Literature
5.	ALA3706108	B	Inhibition Assay: On the day of the uptake experiment, 10 mM HEPES was added to Hank's Balanced Salt Solution, and the pH was adjusted to 7.4 with TRIS (HBSSH). The assay buffer was prepared by adding 100 uM [3H]-taurocholate and 10 uM cold taurocholate to room temperature HBSSH. A separate washing buffer was prepared by adding 10 uM cold taurocholate to HBSSH (30 ml per assay plate) and placed on ice. Using 100% DMSO, 8 point, 3-fold dilution curves for each test compound was prepared starting at 200 uM. Similarly, an 8 point dose response curve was prepared of the control compound [(3R,5R)-3-butyl-3-ethyl-7,8-bis(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine 1,1-dioxide (Brieaddy, L. E. WO9605188, 1996)] starting at 1.8 mM. Drug plates were created by adding 3 uL of each concentration to a v-bottom 96-well plate then diluted 60-fold with 177 uL of assay buffer. Plates were removed from the incubator and allowed to cool to ambient temperature.		72		single protein format	BindingDB Database